Poremba C - Search Results

1

Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.

Poremba C, Scheel C, Hero B, Christiansen H, Schaefer KL, Nakayama Ji, Berthold F, Juergens H, Boecker W, Dockhorn-Dworniczak B. Poremba C, et al. J Clin Oncol. 2000 Jul;18(13):2582-92. doi: 10.1200/JCO.2000.18.13.2582. J Clin Oncol. 2000. PMID: 10893290

2

Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.

Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C, Jürgens H, Böcker W, Dockhorn-Dworniczak B. Poremba C, et al. Ann Oncol. 1999 Jun;10(6):715-21. doi: 10.1023/a:1008333500733. Ann Oncol. 1999. PMID: 10442195 Free article.

3

Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions.

Poremba C, Shroyer KR, Frost M, Diallo R, Fogt F, Schäfer KL, Bürger H, Shroyer AL, Dockhorn-Dworniczak B, Boecker W. Poremba C, et al. J Clin Oncol. 1999 Jul;17(7):2020-6. doi: 10.1200/JCO.1999.17.7.2020. J Clin Oncol. 1999. PMID: 10561253

4

Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.

Poremba C, Hero B, Heine B, Scheel C, Schaefer KL, Christiansen H, Berthold F, Kneif S, Stein H, Juergens H, Boecker W, Dockhorn-Dworniczak B. Poremba C, et al. Med Pediatr Oncol. 2000 Dec;35(6):651-5. doi: 10.1002/1096-911x(20001201)35:6<651::aid-mpo36>3.0.co;2-i. Med Pediatr Oncol. 2000. PMID: 11107139

5

Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.

Poremba C, Hero B, Goertz HG, Scheel C, Wai D, Schaefer KL, Christiansen H, Berthold F, Juergens H, Boecker W, Dockhorn-Dworniczak B. Poremba C, et al. Klin Padiatr. 2001 Jul-Aug;213(4):186-90. doi: 10.1055/s-2001-16850. Klin Padiatr. 2001. PMID: 11528552

6

Population-based genetic alterations in Ewing's tumors from Japanese and European Caucasian patients.

Ozaki T, Schaefer KL, Wai D, Yokoyama R, Ahrens S, Diallo R, Hasegawa T, Shimoda T, Hirohashi S, Kawai A, Naito N, Morimoto Y, Inoue H, Boecker W, Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Poremba C. Ozaki T, et al. Among authors: poremba c. Ann Oncol. 2002 Oct;13(10):1656-64. doi: 10.1093/annonc/mdf218. Ann Oncol. 2002. PMID: 12377657 Free article.

7

Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.

Poremba C, Yandell DW, Metze D, Kamanabrou D, Böcker W, Dockhorn-Dworniczak B. Poremba C, et al. Oncol Res. 1995;7(7-8):331-9. Oncol Res. 1995. PMID: 8747596

8

Adenocarcinoma of the cardia in a young man: detection of somatic p53 mutation by immunohistochemistry and automated direct sequencing.

Poremba C, Yandell DW, Mellin W, Schmid KW, Reers B, Böcker W, Dockhorn-Dworniczak B. Poremba C, et al. Pathol Res Pract. 1995 Oct;191(10):1004-9. doi: 10.1016/s0344-0338(11)80599-6. Pathol Res Pract. 1995. PMID: 8838368

9

Telomerase activity in human proliferative breast lesions.

Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B. Poremba C, et al. Int J Oncol. 1998 Mar;12(3):641-8. doi: 10.3892/ijo.12.3.641. Int J Oncol. 1998. PMID: 9472105

10

Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas.

Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schäfer KL, Terpe HJ, Lampert F, Boecker W, Dockhorn-Dworniczak B. Brinkschmidt C, et al. Among authors: poremba c. Br J Cancer. 1998 Jun;77(12):2223-9. doi: 10.1038/bjc.1998.370. Br J Cancer. 1998. PMID: 9649137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page